{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T15:22:56Z","timestamp":1761578576498,"version":"3.40.5"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","content-domain":{"domain":["lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.lungcan.2014.02.012","type":"journal-article","created":{"date-parts":[[2014,3,2]],"date-time":"2014-03-02T02:46:43Z","timestamp":1393728403000},"page":"175-181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["The potency of curative-intent treatment for advanced thymic carcinoma"],"prefix":"10.1016","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5743-0149","authenticated-orcid":false,"given":"Yusuke","family":"Okuma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotoshi","family":"Horio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Hosomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kageaki","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiharu","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuru","family":"Okamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsunekazu","family":"Hishima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2014.02.012_bib0005","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/ijc.11099","article-title":"Malignant thymoma in the United States: demographic patterns in incidence and associations with subsequent malignancies","volume":"105","author":"Engels","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.lungcan.2014.02.012_bib0010","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/00000478-199003000-00010","article-title":"Histology of the normal thymus","volume":"14","author":"Suster","year":"1990","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.lungcan.2014.02.012_bib0015","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1046\/j.1365-2559.2000.00846.x","article-title":"Cytokeratin profiles of the thymus and thymomas: histogenetic correlations and proposal for a histological classification of thymomas","volume":"36","author":"Kuo","year":"2000","journal-title":"Histopathology"},{"key":"10.1016\/j.lungcan.2014.02.012_bib0020","doi-asserted-by":"crossref","first-page":"S357","DOI":"10.1097\/JTO.0b013e3181f21129","article-title":"The role of chemotherapy in advanced thymoma","volume":"5","author":"Schmitt","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.lungcan.2014.02.012_bib0025","doi-asserted-by":"crossref","first-page":"S1691","DOI":"10.1097\/JTO.0b013e3182254ac1","article-title":"Standard outcome measures for thymic malignancies","volume":"6","author":"Huang","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.lungcan.2014.02.012_bib0030","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/1097-0142(19910215)67:4<1025::AID-CNCR2820670427>3.0.CO;2-F","article-title":"Thymic carcinoma. A clinicopathologic study of 60 cases","volume":"67","author":"Suster","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.lungcan.2014.02.012_bib0035","series-title":"WHO International Histological Classification of Tumours","article-title":"Histological typing of tumors of the thymus","author":"Rosai","year":"1999"},{"year":"2004","series-title":"World Health Organization classification of tumors. Pathology and genetics of tumors of the lung, pleura, thymus and heart","author":"Travis","key":"10.1016\/j.lungcan.2014.02.012_bib0040"},{"key":"10.1016\/j.lungcan.2014.02.012_bib0045","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.athoracsur.2012.09.006","article-title":"Thymic carcinoma: a multivariate analysis of factors predictive of survival in 290 patients","volume":"95","author":"Weksler","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.lungcan.2014.02.012_bib0050","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1200\/JCO.2010.32.9607","article-title":"Phase II study of carboplatin and paclitaxel in advanced thymoma and thymic carcinoma","volume":"29","author":"Lemma","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2014.02.012_bib0055","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1097\/JTO.0b013e31822e71c0","article-title":"Combination chemotherapy with doxorubicin, vincristine, cyclophosphamide, and platinum compounds for advanced thymic carcinoma","volume":"6","author":"Agatsuma","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.lungcan.2014.02.012_bib0060","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/cncr.11606","article-title":"Weekly chemotherapy with cisplatin, vincristine, doxorubicin, and etoposide is an effective treatment for advanced thymic carcinoma","volume":"98","author":"Yoh","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.lungcan.2014.02.012_bib0065","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.lungcan.2009.03.031","article-title":"Efficacy of chemotherapy with carboplatin and paclitaxel for unresectable thymic carcinoma","volume":"67","author":"Igawa","year":"2010","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2014.02.012_bib0070","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.lungcan.2011.05.013","article-title":"Cisplatin and irinotecan combination chemotherapy for advanced thymic carcinoma: evaluation of efficacy and toxicity","volume":"74","author":"Okuma","year":"2011","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2014.02.012_bib0075","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1309\/3PDN-PMT5-EQTM-H0CD","article-title":"Neuroendocrine carcinomas (carcinoid tumor) of the thymus. A clinicopathologic analysis of 80 cases","volume":"114","author":"Moran","year":"2000","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.lungcan.2014.02.012_bib0080","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2013.31.15_suppl.7529","article-title":"A multicenter prospective study of carboplatin and paclitaxel for advanced thymic carcinoma:West Japan Oncology Group 4207L","volume":"31","author":"Takeda","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2014.02.012_bib0085","doi-asserted-by":"crossref","first-page":"S365","DOI":"10.1097\/JTO.0b013e3181f22d01","article-title":"International thymic malignancies interest group: a way forward","volume":"5","author":"Detterbeck","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.lungcan.2014.02.012_bib0090","doi-asserted-by":"crossref","first-page":"S352","DOI":"10.1097\/JTO.0b013e3181f20f3b","article-title":"Tumor-node metastasis staging system for thymic epithelial tumors","volume":"5","author":"Kondo","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.lungcan.2014.02.012_bib0095","first-page":"S1689","article-title":"ITMIG Definitions and Policies","volume":"6","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.lungcan.2014.02.012_bib0100","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/JTO.0b013e3181653c71","article-title":"Thymic carcinoma: 30 cases at a single institution","volume":"3","author":"Yano","year":"2008","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.lungcan.2014.02.012_bib0105","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.lungcan.2012.12.003","article-title":"Messenger RNA and protein expression of thymidylate synthase and DNA repair genes in thymic tumors","volume":"79","author":"Monica","year":"2013","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2014.02.012_bib0110","first-page":"31","article-title":"Thymic carcinoma: a cohort study of prognostic factors after surgical resection from the European Society of Thoracic Surgeons database","author":"Ruffini","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2014.02.012_bib0115","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1002\/cncr.10588","article-title":"Treatment and prognosis of thymic carcinoma: a retrospective analysis of 40 cases","volume":"94","author":"Ogawa","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.lungcan.2014.02.012_bib0120","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0003-4975(03)00555-1","article-title":"Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan","volume":"76","author":"Kondo","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.lungcan.2014.02.012_bib0125","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0022-5223(96)70409-9","article-title":"Thymic neuroendocrine carcinoma (carcinoid): a clinicopathologic study of fourteen cases","volume":"111","author":"de Montpreville","year":"1996","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.lungcan.2014.02.012_bib0130","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1309\/AJCP88FZTWANLRCB","article-title":"Thymic carcinoma, part 1: a clinicopathologic and immunohistochemical study of 65 cases","volume":"138","author":"Weissferdt","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.lungcan.2014.02.012_bib0135","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1016\/j.athoracsur.2005.07.019","article-title":"Proposal of a novel system for the staging of thymic epithelial tumors","volume":"80","author":"Bedini","year":"2005","journal-title":"Ann Thorac Surg"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500214000981?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500214000981?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T22:45:02Z","timestamp":1597531502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500214000981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0169500214000981"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2014.02.012","relation":{},"ISSN":["0169-5002"],"issn-type":[{"type":"print","value":"0169-5002"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The potency of curative-intent treatment for advanced thymic carcinoma","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2014.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}